Mottola Frank
- SEC CIK
- 0001804567
In the past year, 2 open-market sale filings worth $1.10M and no purchases.
Current role at each company
- SUPN Supernus Pharmaceuticals, Inc.SVP, Chief Tech. Ops. Officeras of Aug 14, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.10M
- 2 filings
- Net
- −$1.10M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Mottola Frank as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 (view filing) | Mar 9 | 1 day | Mottola FrankSVP, Chief Tech. Ops. Officer | SSale | −1.62K | $53.65 | −$87.1K | −8.1%18.4K after | |
| Dec 22, 2025 (view filing) | Dec 19 | 3 days | Mottola FrankSVP, Chief Tech. Ops. Officer | SSale | −20.0K | $50.41 | −$1.01M | −56.3%15.5K after | 2 lots10b5-1 |
| Sep 15, 2025 (view filing) | Sep 12 | 3 days | Mottola FrankSVP, Chief Tech. Ops. Officer | SSale | −5.00K | $45.87 | −$229.3K | −24.4%15.5K after | |
| Aug 27, 2025 (view filing) | Aug 25 | 2 days | Mottola FrankSVP, Quality, GMP, Ops, IT | SSale | −14.0K | $44.51 | −$623.1K | −47.5%15.5K after | |
| Nov 8, 2024 (view filing) | Nov 7 | 1 day | Mottola FrankSVP, Quality, GMP, Ops, IT | SSale | −15.0K | $36.98 | −$554.7K | −64.7%8.20K after | |
| Nov 16, 2023 (view filing) | Nov 14 | 2 days | Mottola FrankSVP, Quality, GMP, Ops, IT | SSale | −1.11K | $28.13 | −$31.2K | −16.3%5.68K after | |
| Mar 16, 2023 (view filing) | Mar 14 | 2 days | Mottola FrankSr VP, Quality, GMP Oper. & IT | SSale | −4.78K | $35.99 | −$172.0K | −50.2%4.74K after |